Literature DB >> 30382935

MicroRNA-30c targets the interferon-alpha/beta receptor beta chain to promote type 2 PRRSV infection.

Fang Liu1,2, Honglei Wang1,2, Li Du1,2, Zeyu Wei1,2, Qiong Zhang1,2, Wen-Hai Feng2,1.   

Abstract

Porcine reproductive and respiratory syndrome (PRRS) is one of the most important diseases in pigs. MicroRNAs (miRNAs) have emerged as an important regulator of virus-host cell interactions and miR-30c has been found to facilitate PRRSV replication. Here, we found that the interferon-alpha/beta receptor beta chain (IFNAR2) was down-regulated, while miR-30c was up-regulated during HV (a highly pathogenic type 2 PRRSV strain) and CH-1a (a classic type 2 PRRSV strain) infection. Subsequently, using bioinformatics analysis, we predicted that the IFNAR2 was targeted by miR-30c. A luciferase assay verified that the 3' UTR of IFNAR2 was targeted by miR-30c, as a mutation on either the target sequence or the miR-30c seed sequence reversed the luciferase activity. In addition, miR-30c and IFNAR2 mRNA were physically co-localized in RNA-induced silencing complex (RISC). Importantly, we showed that miR-30c also impaired the induction of IFN-stimulated genes (ISGs) by targeting IFNAR2. Our findings further reveal the mechanism of miR-30c promoting PRRSV replication.

Entities:  

Keywords:  IFN-I; IFNAR2; PRRSV; miR-30c

Mesh:

Substances:

Year:  2018        PMID: 30382935     DOI: 10.1099/jgv.0.001166

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Downregulation of miR-296-3p by highly pathogenic porcine reproductive and respiratory syndrome virus activates the IRF1/TNF-α signaling axis in porcine alveolar macrophages.

Authors:  Yanbing Zhang; Xiao Xiang; Yan Lu; Hui Li; Abdul Wahaab; Mona Sharma; Ke Liu; Jianchao Wei; Zongjie Li; Donghua Shao; Beibei Li; Zhiyong Ma; Yafeng Qiu
Journal:  Arch Virol       Date:  2021-01-04       Impact factor: 2.574

2.  Gga-miR-30c-5p Enhances Apoptosis in Fowl Adenovirus Serotype 4-Infected Leghorn Male Hepatocellular Cells and Facilitates Viral Replication through Myeloid Cell Leukemia-1.

Authors:  Areayi Haiyilati; Linyi Zhou; Jiaxin Li; Wei Li; Li Gao; Hong Cao; Yongqiang Wang; Xiaoqi Li; Shijun J Zheng
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

Review 3.  Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons.

Authors:  Soudeh Ghafouri-Fard; Yadollah Poornajaf; Farzaneh Dashti; Bashdar Mahmud Hussen; Mohammad Taheri; Elena Jamali
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

4.  The Coronavirus PEDV Evades Type III Interferon Response Through the miR-30c-5p/SOCS1 Axis.

Authors:  Changlin Wang; Lingling Shan; Shuxin Qu; Mei Xue; Keliang Wang; Fang Fu; Lu Wang; Ziqi Wang; Li Feng; Wanhai Xu; Pinghuang Liu
Journal:  Front Microbiol       Date:  2020-05-22       Impact factor: 5.640

Review 5.  Molecular and Cellular Mechanisms for PRRSV Pathogenesis and Host Response to Infection.

Authors:  Tong-Qing An; Jiang-Nan Li; Chia-Ming Su; Dongwan Yoo
Journal:  Virus Res       Date:  2020-04-18       Impact factor: 3.303

6.  MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication Via Targeting Tripartite Motif Protein 25.

Authors:  Jia Li; Yewei Xie; Liwei Li; Xiaobing Li; Li Shen; Jin Gong; Rufang Zhang
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

Review 7.  Porcine Reproductive and Respiratory Syndrome Virus Evades Antiviral Innate Immunity via MicroRNAs Regulation.

Authors:  Xuan Zhang; Wen-Hai Feng
Journal:  Front Microbiol       Date:  2021-12-15       Impact factor: 5.640

8.  MiR-140 inhibits classical swine fever virus replication by targeting Rab25 in swine umbilical vein endothelial cells.

Authors:  Panpan Xu; Shuangkai Jia; Kai Wang; Zhixin Fan; Hongqing Zheng; Jiangman Lv; Yanfen Jiang; Yufeng Hou; Bihao Lou; Hongchao Zhou; Yanming Zhang; Kangkang Guo
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.